Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CLINIQUE BELLEVUE AS
AS
Active
Org 918082379
Muségata 18, 4010 Stavanger
Other human health activities n.e.c. · NACE 8699
Est. 2016
2 employees
cliniquebellevue.no
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 10,5M
+16% vs 2023
EBITDA margin
11.0%
+26% vs 2023
Equity ratio
-138.2%
Financial strength
Net profit 2024
NOK 900K
+29% vs 2023
EBITDA — year on year
NOK millions
1M
1M
0M
-1M
-1M
1M
2020
-1M
-200%
2021
0M
+100%
2022
1M
+100%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 10,5M
+16%
EBITDA
NOK 1,2M
+26%
Net profit
NOK 900K
+29%
Total assets
NOK 2,1M
+18%
Equity
NOK -3M
+23%
Employees
2
—
Company information
Legal name
CLINIQUE BELLEVUE AS
Org number
918082379
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
21. november 2016
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legevirksomhet og kosmetisk hudpleie.
Contact
Address
Muségata 18, 4010 Stavanger
Phone
+4751317550
Email
post@klinikk-bv.no
Website
cliniquebellevue.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
3M
6M
9M
12M
10M
2020
8M
2021
8M
2022
9M
2023
10M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2020
-1M
2021
0M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
9 602
7 876
8 028
9 024
10 487
Staff expenses
−986
−639
−948
−991
−1 010
EBITDA
693
−504
172
921
1 158
Depreciation & amort.
−112
−144
−210
−225
−258
EBIT
581
−647
−38
696
901
Net financials
−1
1
−4
0
−1
Profit before tax
581
−646
−42
696
900
Tax
−0
−0
−0
−0
−0
Net profit
581
−646
−42
696
900
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 035
1 917
1 856
1 807
2 141
Equity
−3 867
−4 514
−4 556
−3 859
−2 959
Long-term debt
0
0
0
0
0
Short-term debt
5 852
6 431
6 411
5 667
5 101
Total debt
5 852
6 431
6 411
5 667
5 101
Financial ratios
5-year trend
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
2020
2024
Equity ratio
-138.2%
This company
38.2%
Market median
-462% vs market
2020
2024
Return on equity
90000800.0%
This company
18.4%
Market median
+489134683% vs market
2020
2024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
2020
2024
Asset turnover
4.90×
This company
1.12×
Market median
+338% vs market
2020
2024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AZ
Ayman Zakaria
Chief Executive Officer
Chief Executive Officer
2016
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Norwayaz As
Company
90%
90%
2024
Unknown
Individual
10%
10%
2022
Helge Torolf Holst-Larsen
Individual
10%
10%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CLINIQUE BELLEVUE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ayman Zakaria
Chief Executive Officer
0 companies